| NGB Protein |
| Gene | [NGB](/genes/ngb) |
| UniProt ID | [Q9NWY2](https://www.uniprot.org/uniprot/Q9NWY2) |
| Molecular Weight | ~17 kDa |
| Subcellular Localization | Cytosolic, neuron-specific |
| Protein Family | Globin family |
| PDB Structures | [1OJ6](https://www.ebi.ac.uk/pdbe/entry/pdb/1oj6), [2ZM4](https://www.ebi.ac.uk/pdbe/entry/pdb/2zm4) |
Neuroglobin (NGB) is a neuronal-specific globin protein that provides neuroprotection against hypoxia, oxidative stress, and neurodegenerative diseases. Unlike hemoglobin and myoglobin, neuroglobin is primarily expressed in the brain and peripheral nervous system, where it plays a critical role in neuronal survival under conditions of metabolic stress.
Neuroglobin is a heme-containing protein with a distinctive three-dimensional fold:
- Heme pocket: Contains a heme b prosthetic group with iron center
- Globin fold: Similar to myoglobin but with unique structural features
- Dimerization interface: Can form homodimers under certain conditions
- Tyr B10 and Gln E7: Key residues affecting oxygen affinity
The crystal structure reveals a typical globin fold with a 6-coordinated heme iron, distinguishing it from most other globins which are 5-coordinated.
Neuroglobin performs several critical functions in neurons:
- Oxygen storage and delivery: Provides oxygen reserve during hypoxia
- ROS scavenging: Neutralizes reactive oxygen species
- Nitric oxide detoxification: Protects against NO-mediated toxicity
- Mitochondrial function: Preserves mitochondrial integrity under stress
- Synaptic transmission: Modulates neurotransmitter release
NGB is expressed throughout the brain, with highest levels in the cortex, hippocampus, and cerebellum. It is primarily localized in neurons, with lower expression in glial cells.
Neuroglobin is downregulated in Alzheimer's disease brains:
- Amyloid toxicity: A-beta exposure reduces NGB expression
- Oxidative stress: NGB protects against ROS accumulation
- Mitochondrial protection: Preserves neuronal energy metabolism
- Therapeutic potential: NGB overexpression improves cognitive function in AD models
NGB provides neuroprotection in PD models:
- Dopaminergic neuron survival: Protects against MPTP toxicity
- Alpha-synuclein interaction: May bind aggregated alpha-synuclein
- Mitochondrial complex I: Protects against Complex I dysfunction
- Neuroinflammation: Modulates microglial activation
¶ Stroke and Hypoxia-Ischemia
- NGB is upregulated in response to hypoxic preconditioning
- Provides neuroprotection against ischemic injury
- Therapeutic window extends beyond immediate reperfusion
- NGB expression is altered in ALS motor neurons
- May protect against oxidative stress and mitochondrial dysfunction
- Potential therapeutic target for motor neuron disease
NGB represents a promising therapeutic target:
- Recombinant NGB protein: Being developed for neuroprotective therapy
- Small molecule inducers: Drugs that upregulate NGB expression
- Gene therapy: AAV-mediated NGB delivery in preclinical models
- Neuroprotective peptides: NGB-derived neuroprotective sequences
Neuroglobin interacts with multiple cellular pathways:
- Mitochondrial complexes: Binds to Complex I, III, and IV
- Cytoglobin: Forms heterodimers with related globin
- Amyloid-beta: May interact with A-beta aggregates
- Apoptotic proteins: Modulates BAX and BCL-2 pathways
- MAPK signaling: Activates protective signaling cascades
- Neuroglobin protects against Alzheimer's disease pathology (2019)
- Neuroglobin upregulation in Parkinson's disease models (2020)
- Structure and function of neuroglobin (2021)
- Neuroglobin as a therapeutic target for neurodegeneration (2022)
- Oxygen sensing by neuroglobin in the brain (2023)